Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-23-156925
Filing Date
2023-05-31
Accepted
2023-05-30 21:02:28
Documents
2

Document Format Files

Seq Description Document Type Size
1 DEFA14A d444153ddefa14a.htm DEFA14A 50695
2 GRAPHIC g444153dsp18.jpg GRAPHIC 3457
  Complete submission text file 0001193125-23-156925.txt   56683
Mailing Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130 858-369-7100
MEI Pharma, Inc. (Filer) CIK: 0001262104 (see all company filings)

EIN.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: DEFA14A | Act: 34 | File No.: 000-50484 | Film No.: 23978685
SIC: 2834 Pharmaceutical Preparations